Stoke Therapeutics Stock Technical Analysis
| STOK Stock | USD 14.37 0.59 4.28% |
As of the 31st of May, Stoke Therapeutics has the Semi Deviation of 3.81, coefficient of variation of 831.8, and Risk Adjusted Performance of 0.0822. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Stoke Therapeutics, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to break down and interpolate data for nineteen technical drivers for Stoke Therapeutics, which can be compared to its competition. Please validate Stoke Therapeutics variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Stoke Therapeutics is priced more or less accurately, providing market reflects its prevalent price of 14.37 per share. Given that Stoke Therapeutics has jensen alpha of 1.13, we advise you to double-check Stoke Therapeutics's current market performance to make sure the company can sustain itself at a future point.
Stoke Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Stoke, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to StokeStoke |
Stoke Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 22.0 | Strong Buy | 9 | Odds |
Most Stoke analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Stoke stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Stoke Therapeutics, talking to its executives and customers, or listening to Stoke conference calls.
Stoke Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Stoke Therapeutics Technical Analysis
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Stoke Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Stoke Therapeutics Trend Analysis
Use this graph to draw trend lines for Stoke Therapeutics. You can use it to identify possible trend reversals for Stoke Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Stoke Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Stoke Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Stoke Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.12 , which means Stoke Therapeutics will continue generating value for investors. It has 122 observation points and a regression sum of squares at 571.84, which is the sum of squared deviations for the predicted Stoke Therapeutics price change compared to its average price change.About Stoke Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Stoke Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Stoke Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Stoke Therapeutics price pattern first instead of the macroeconomic environment surrounding Stoke Therapeutics. By analyzing Stoke Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Stoke Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Stoke Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 (projected) | Payables Turnover | 2.79 | 1.64 | Days Of Inventory On Hand | 1.0K | 903.01 |
Stoke Therapeutics May 31, 2024 Technical Indicators
Most technical analysis of Stoke help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Stoke from various momentum indicators to cycle indicators. When you analyze Stoke charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0822 | |||
| Market Risk Adjusted Performance | 0.3827 | |||
| Mean Deviation | 5.44 | |||
| Semi Deviation | 3.81 | |||
| Downside Deviation | 4.39 | |||
| Coefficient Of Variation | 831.8 | |||
| Standard Deviation | 9.82 | |||
| Variance | 96.44 | |||
| Information Ratio | 0.1178 | |||
| Jensen Alpha | 1.13 | |||
| Total Risk Alpha | 0.9513 | |||
| Sortino Ratio | 0.2638 | |||
| Treynor Ratio | 0.3727 | |||
| Maximum Drawdown | 65.31 | |||
| Value At Risk | (6.96) | |||
| Potential Upside | 11.78 | |||
| Downside Variance | 19.23 | |||
| Semi Variance | 14.5 | |||
| Expected Short fall | (7.71) | |||
| Skewness | 3.93 | |||
| Kurtosis | 19.64 |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stoke Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Stoke Stock please use our How to buy in Stoke Stock guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Stoke Stock analysis
When running Stoke Therapeutics' price analysis, check to measure Stoke Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stoke Therapeutics is operating at the current time. Most of Stoke Therapeutics' value examination focuses on studying past and present price action to predict the probability of Stoke Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stoke Therapeutics' price. Additionally, you may evaluate how the addition of Stoke Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
Is Stoke Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stoke Therapeutics. If investors know Stoke will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stoke Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.36) | Revenue Per Share 0.175 | Quarterly Revenue Growth (0.18) | Return On Assets (0.30) | Return On Equity (0.61) |
The market value of Stoke Therapeutics is measured differently than its book value, which is the value of Stoke that is recorded on the company's balance sheet. Investors also form their own opinion of Stoke Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Stoke Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stoke Therapeutics' market value can be influenced by many factors that don't directly affect Stoke Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stoke Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Stoke Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stoke Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.